BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Genetown

  KalVista Pharmaceuticals Announces Pricing of an Upsized $193.5 Million Public Offering of Common Stock

  KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the pricing of its upsized underwritten public offering of 5,375,000 shares of its common stock at a price to the public of $36.00 per share.

  February 10, 2021

   · 

  5 min read
• Deals

  Onconova Therapeutics, Inc. Announces Pricing of $25 Million Public Offering of Common Stock - Feb 11, 2021

  Onconova Therapeutics, Inc., a biopharmaceutical company focused on discovering and developing novel products to treat cancer, announced the pricing of an underwritten public offering of 25,000,000 shares of its common stock at a public offering price of $1.00 per share.

  February 10, 2021

   · 

  4 min read
• Positivity Around Vaccine Roll-Out and Future Availability Leads to Improved Perceptions on Whole Health

  Cigna’s International Markets business published the fifth edition of its COVID-19 Global Impact Study, which highlights the contrast in well-being around the world as vaccine roll-out commenced for some, while other markets anticipated vaccine approvals to come.

  February 10, 2021

   · 

  7 min read
• Deals

  Bioventus Announces Pricing of Initial Public Offering - Feb 11, 2021

  Bioventus Inc. announced the pricing of its initial public offering of 8,000,000 shares of Class A common stock at a public offering price of $13.00 per share.

  February 10, 2021

   · 

  2 min read
• Increasing Levels of Adoption and Cosmetology-Related Demands Will Drive Skin Cooling Systems Market to Greater Lengths, Expects Fact.MR

  Skin cooling systems work by chilling the skin layer, thereby minimizing the pain at the injury or pain point.

  February 10, 2021

   · 

  4 min read
• Canine Influenza Treatment Demand Driven by High Unmet Requirement for Treatment of Canine Flu, Says Fact.MR

  Fact.MR, a global research & consulting firm, in their updated edition of the report, projected that the canine influenza treatment market is poised to witness a robust growth in 2021 & beyond.

  February 10, 2021

   · 

  4 min read
• Facial Spasm Treatment Demand Augmented by Growing Awareness of the Treatment Options, Says Fact.MR

  Fact.MR, a global research & consulting firm, in their updated edition of the report, projected that the facial spasm treatment market is slated to grow steadily in 2021 & beyond.

  February 10, 2021

   · 

  4 min read
• Neuroprotective Agents Market: Increase in Stroke and Traumatic Central Nervous System Injuries to drive the market

  Neuroprotection or prevention of neuronal loss is a complicated molecular process that is mediated by various cellular pathways.

  February 10, 2021

   · 

  3 min read
• Renal Biomarkers Market: Rapidly increasing incidence of cardiovascular diseases and diabetes propel the market

  Biomarker is a measurable biological indicator of the health status of an individual, especially of one at the risk of developing or presence of a particular disease.

  February 10, 2021

   · 

  5 min read
• Personalized Retail Nutrition and Wellness Market in 2021 | Detailed Study Analysis

  The global market for personalized retail and wellness has witnessed a plausible rise in its valuation as well as its global outreach in the past few years.

  February 10, 2021

   · 

  4 min read